Bristol-Myers Squibb: all 2,184 studies

Page 22 of 22. Open to participants first (162), then studies with results posted, then the rest; newest registration first within each.

• Irbesartan Versus Placebo in Combination With Ramipril for Treatment of AlbuminuriaCompletedNCT00095290Phase 4
• Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney CancerCompletedNCT00095108Phase 1
• Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin AloneCompletedNCT00095030Phase 3
• Mechanism of Action and Efficacy of Muraglitazar in Type 2 DiabetesCompletedNCT00094991Phase 3
• A Safety Study of ABI-007 for In-Stent RestenosisCompletedNCT00093223Phase 2
• Trial of ABI-007 in Previously Treated Patients With Metastatic MelanomaCompletedNCT00093119Phase 2
• A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)CompletedNCT00091624Phase 1
• Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive PatientsCompletedNCT00084253Phase 4
• Study of MDX-010 in Stage IV Breast CancerCompletedNCT00083278Phase 2
• Effectiveness of KOS-862 in the Treatment of Lung CancerTerminatedNCT00080509Phase 2
• Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade GliomasCompletedNCT00074646Phase 1
• Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00073723Phase 1/2
• Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)CompletedNCT00072722Phase 2
• A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral TherapyCompletedNCT00067782Phase 3
• A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS)CompletedNCT00067743Phase 2
• Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple MyelomaCompletedNCT00065351Phase 2
• Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic SyndromesCompletedNCT00064974Phase 2
• Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.CompletedNCT00057616Phase 3
• A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple MyelomaCompletedNCT00057564Phase 3
• A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid TumorsCompletedNCT00057473Phase 2
• Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant MelanomaCompletedNCT00055562Phase 2/3
• A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple MyelomaCompletedNCT00051116Phase 2
• Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected PatientsCompletedNCT00051038Phase 2/3
• A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic SyndromesCompletedNCT00050843Phase 3
• Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate CancerCompletedNCT00050596Phase 2
• Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic MelanomaCompletedNCT00050102Phase 2
• D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer PatientsCompletedNCT00047476Phase 2
• Phase 1 Study OF CDC-501 in Patients With Solid TumorsCompletedNCT00046735Phase 1
• Study of ABI-007 and Taxol in Patients With Metastatic Breast CancerCompletedNCT00046527Phase 3
• ABI-007 in Taxol Resistant Patients With Metastatic Breast CancerCompletedNCT00046514Phase 2
• A Trial of ABI-007 in Patients With Advanced Non-Hematologic MalignanciesCompletedNCT00046423Phase 1
• Atazanavir for HIV Infected Individuals: An Early Access ProgramNo longer availableNCT00046345
• Study to Determine the Safety and Preliminary Efficacy of CC-1088 in the Treatment of Myelodysplastic SyndromesCompletedNCT00045786Phase 2
• Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic SyndromeCompletedNCT00044382Phase 2
• CDC-501 Therapy in Relapsed or Refractory Multiple MyelomaCompletedNCT00044018Phase 2
• A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal CancerTerminatedNCT00040391Phase 2
• A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal TherapyTerminatedNCT00036621Phase 2
• A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to LamivudineCompletedNCT00036608Phase 3
• A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e AntigenCompletedNCT00035789Phase 3
• A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E AntigenCompletedNCT00035633Phase 3
• A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 DiabetesCompletedNCT00035568Phase 4
• A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.CompletedNCT00035542Phase 3
• A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple SclerosisTerminatedNCT00035529Phase 2
• Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung CancerCompletedNCT00035152Phase 3
• A Trial to Evaluate Epothilone D in Patients With Advanced Solid TumorsCompletedNCT00030173Phase 1
• Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)CompletedNCT00028301Phase 3
• A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease InhibitorTerminatedNCT00028067Phase 3
• Carboplatin and Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00024284Phase 1
• BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With ChemotherapyCompletedNCT00017043Phase 2
• A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-LamivudineCompletedNCT00013897Phase 3
• Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected PatientsCompletedNCT00005918Phase 3
• Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous TreatmentCompletedNCT00004584Phase 2
• Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug RegimenCompletedNCT00002429Phase 3
• The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease InhibitorsTerminatedNCT00002420Phase 2
• The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease InhibitorsTerminatedNCT00002418Phase 2
• A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV DrugsCompletedNCT00002411Not applicable
• The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken ZidovudineCompletedNCT00002371Phase 3
• A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsCompletedNCT00002369Not applicable
• A Study Comparing Two Forms of Didanosine in HIV-infected PatientsCompletedNCT00002360Phase 1
• A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZVCompletedNCT00002358Phase 3
• A Study of Lobucavir in Patients With AIDSCompletedNCT00002352Not applicable
• A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.CompletedNCT00002349Not applicable
• The Safety and Effectiveness of Megace in HIV-Infected WomenCompletedNCT00002345Phase 4
• A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV DrugsCompletedNCT00002308Not applicable
• A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected PatientsCompletedNCT00002307Not applicable
• A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and MalnutritionCompletedNCT00002300Phase 2
• A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related SyndromesCompletedNCT00002293Not applicable
• A Study of ddI in Children With AIDS Who Have Not Had Success With ZidovudineCompletedNCT00002280Not applicable
• A Study of ddI in Patients With AIDS Who Become Sicker While Taking ZidovudineCompletedNCT00002274Not applicable
• A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated VolunteersCompletedNCT00002261Phase 1
• A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia ComplexCompletedNCT00002246Phase 3
• Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV DrugsCompletedNCT00002240Phase 2
• Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)CompletedNCT00002224Phase 3
• A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected PatientsCompletedNCT00002207Not applicable
• A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV InfectionCompletedNCT00002177Not applicable
• A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV InfectionCompletedNCT00002176Not applicable
• A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected PatientsCompletedNCT00002168Not applicable
• Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting SyndromeCompletedNCT00002157Not applicable
• A Phase II, Parallel Group, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Thalidomide in Reducing Weight Loss in Adults With HIV Wasting SyndromeCompletedNCT00002127Phase 2
• A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and CachexiaCompletedNCT00002067Phase 3
• Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARCCompletedNCT00002057Not applicable
• Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised PatientsCompletedNCT00002041Not applicable
• Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With ZidovudineCompletedNCT00002035Not applicable
• A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir)CompletedNCT00002028Not applicable

← Bristol-Myers Squibb overview and focus areas